TeleMD, a Russian start-up, has developed a software platform that uses artificial intelligence (AI) for cancer diagnostics and prognostication.

The platform’s functionality enables image recognition for cancer diagnostics, and also scalability for medical specialists from across disciplines who are now able to analyze heterogeneous medical data.

The TeleMD platform is designed to make it possible for physicians to diagnose and predict oncologic developments in complicated cases by analyzing medical images and other patient-specific data. With the solution, doctors may expect to be able to reach out to broader medical communities and get remote advice.